A new predictive biomarker enables more accurate PD-1 blockade therapy
- PMID: 33558685
- PMCID: PMC8245455
- DOI: 10.1038/s41423-021-00645-4
A new predictive biomarker enables more accurate PD-1 blockade therapy
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment on
-
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.Nat Immunol. 2020 Nov;21(11):1346-1358. doi: 10.1038/s41590-020-0769-3. Epub 2020 Aug 31. Nat Immunol. 2020. PMID: 32868929
Similar articles
-
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy.Recent Pat Anticancer Drug Discov. 2016;11(2):141-51. doi: 10.2174/1574892811666160226150506. Recent Pat Anticancer Drug Discov. 2016. PMID: 26916881 Review.
-
Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.Front Immunol. 2018 Mar 5;9:374. doi: 10.3389/fimmu.2018.00374. eCollection 2018. Front Immunol. 2018. PMID: 29556232 Free PMC article. Review.
-
Systemic CD4 immunity: A powerful clinical biomarker for PD-L1/PD-1 immunotherapy.EMBO Mol Med. 2020 Sep 7;12(9):e12706. doi: 10.15252/emmm.202012706. Epub 2020 Jul 10. EMBO Mol Med. 2020. PMID: 32648370 Free PMC article.
-
Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway.J Biomed Sci. 2019 Dec 5;26(1):96. doi: 10.1186/s12929-019-0588-8. J Biomed Sci. 2019. PMID: 31801525 Free PMC article. Review.
-
A potential biomarker for anti-PD-1 immunotherapy.Nat Med. 2018 Feb 7;24(2):123-124. doi: 10.1038/nm.4489. Nat Med. 2018. PMID: 29414936 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources